Legend Biotech (LEGN) Operating Expenses (2019 - 2025)

Legend Biotech's Operating Expenses history runs 7 years deep, the most recent figure standing at -$138.3 million for Q4 2025.

• Quarterly Operating Expenses changed 0.22% year-over-year to -$138.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$550.5 million (changed 0.03% YoY) and the FY2025 annual result came in at -$550.5 million, changed 0.04% from the prior year.
• Operating Expenses was -$138.3 million for Q4 2025 at Legend Biotech, up from -$147.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at -$79836.0 in Q1 2021 and bottomed at -$172.4 million in Q2 2021.
• A 5-year average of -$111.6 million and a median of -$125.9 million in 2022 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses slumped 117898.15% — and 2023, when it soared 99.87%.
• Legend Biotech's Operating Expenses stood at -$103.6 million in 2021, then retreated by 3.66% to -$107.4 million in 2022, then surged by 99.87% to -$134390.0 in 2023, then sank by 103032.67% to -$138.6 million in 2024, then increased by 0.22% to -$138.3 million in 2025.
• Business Quant data shows LEGN's Operating Expenses at -$138.3 million in Q4 2025, -$147.9 million in Q3 2025, and -$130.9 million in Q2 2025.